Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
8.00
0.26 (3.36%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.00%
After-hours: Aug 15, 2025, 04:01 PM EDT
Enanta Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 64.81M | 64.46M | 66.59M | 67.64M | 71.96M | 72.88M | 73.62M | 79.2M | 80.59M | 81.18M | 82.1M | 86.16M | 89.42M | 91.56M | 92.98M | 97.07M | 97.13M | 94.16M | 101.65M |
Cost of Revenue | 2.57M | 3.17M | 2.58M | 2.34M | 2.53M | 1.93M | 1.85M | 1.72M | 1.71M | 2.42M | 1.88M | 1.37M | 716K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 14.61M | 64.46M | 66.59M | 67.64M | 71.96M | 72.88M | 73.08M | 78.15M | 78.88M | 78.75M | 80.22M | 84.79M | 88.7M | 91.56M | 92.98M | 97.07M | 97.13M | 94.16M | 101.65M |
Operating Income | -96.82M | -102.11M | -110.35M | -121.69M | -122.87M | -135.4M | -142.08M | -137.21M | -133.22M | -129.05M | -123.45M | -123.84M | -130.52M | -131.83M | -127.68M | -109.57M | -95.63M | -84.63M | -66.81M |
Interest Income | 10.55M | 11.75M | 13.27M | 14.77M | 16.26M | 16.64M | 14.66M | 11.36M | 6.7M | 3.22M | 1.64M | 648K | 648K | 255K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -94.07M | -98.89M | -106.47M | -117.79M | -118.12M | -129.91M | -136M | -131M | -127.81M | -125.11M | -121.09M | -122.22M | -129.28M | -130.54M | -126.11M | -107.58M | -92.82M | -80.82M | -61.59M |
Net Income | -92.01M | -96.42M | -104.93M | -116.05M | -115.33M | -131.74M | -138.24M | -133.82M | -132.06M | -124.69M | -120.37M | -121.5M | -119.75M | -112.08M | -100.78M | -79M | -83.74M | -73.98M | -57.94M |
Selling & General & Admin | 47.91M | 51.33M | 54.18M | 57.85M | 57.96M | 57.17M | 56.71M | 52.89M | 51.66M | 51.97M | 48.67M | 45.48M | 41.27M | 36.82M | 34.67M | 32.54M | 30.91M | 29.25M | 27.81M |
Research & Development | 113.71M | 115.24M | 122.76M | 131.48M | 136.87M | 151.11M | 158.99M | 163.52M | 162.15M | 158.26M | 156.88M | 164.52M | 178.67M | 186.58M | 186M | 174.11M | 161.85M | 149.54M | 140.64M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 393K | 648K | 906K | 1.24M | 1.28M | 1.03M | 772K | 439K | n/a | n/a |
Operating Expenses | 161.62M | 166.57M | 176.94M | 189.33M | 194.83M | 208.28M | 215.7M | 216.41M | 213.81M | 210.23M | 205.54M | 210M | 219.94M | 223.39M | 220.66M | 206.65M | 192.76M | 178.79M | 168.46M |
Interest Expense | 7.88M | 8.61M | 9.46M | 10.94M | 11.51M | 11.15M | 8.59M | 5.15M | 2M | n/a | n/a | n/a | n/a | n/a | 545K | 545K | 545K | 545K | 1.95M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 161.62M | 166.57M | 176.94M | 189.33M | 194.83M | 208.28M | 215.7M | 216.41M | 213.81M | 210.23M | 205.54M | 210M | 219.94M | 223.39M | 220.66M | 206.65M | 192.76M | 178.79M | 168.46M |
Income Tax Expense | -2.06M | -2.48M | -1.54M | -1.74M | -2.79M | 1.83M | 2.23M | 2.82M | 4.25M | -423K | -722K | -724K | -9.53M | -18.47M | -25.32M | -28.58M | -9.08M | -6.84M | -3.65M |
Shares Outstanding (Basic) | 21.32M | 21.36M | 21.24M | 21.19M | 21.18M | 21.17M | 21.09M | 21.06M | 21.05M | 21.04M | 20.82M | 20.6M | 20.71M | 20.55M | 20.39M | 20.18M | 20.19M | 20.17M | 20.09M |
Shares Outstanding (Diluted) | 21.32M | 21.36M | 21.24M | 21.19M | 21.18M | 21.17M | 21.09M | 21.06M | 21.05M | 21.04M | 20.82M | 20.6M | 20.71M | 20.55M | 20.39M | 20.22M | 20.2M | 20.17M | 20.09M |
EPS (Basic) | -4.32 | -4.54 | -4.95 | -5.48 | -5.45 | -6.24 | -6.56 | -6.37 | -6.32 | -5.99 | -5.82 | -5.91 | -5.85 | -5.51 | -4.98 | -3.91 | -4.15 | -3.67 | -2.88 |
EPS (Diluted) | -4.32 | -4.54 | -4.95 | -5.48 | -5.45 | -6.24 | -6.56 | -6.37 | -6.32 | -5.99 | -5.82 | -5.91 | -5.85 | -5.51 | -4.98 | -3.91 | -4.15 | -3.67 | -2.88 |
EBITDA | -83.62M | -87.12M | -94.42M | -104.51M | -104.08M | -116.17M | -124.91M | -123.48M | -124.17M | -123.41M | -119.36M | -120.48M | -127.01M | -128.6M | -124.44M | -106.24M | -92.19M | -81.1M | -63.2M |
EBIT | -86.19M | -90.28M | -97M | -106.85M | -106.61M | -118.76M | -127.42M | -125.85M | -126.53M | -125.83M | -122.06M | -123.45M | -130.13M | -131.83M | -127.68M | -109.57M | -95.63M | -84.63M | -66.81M |
Depreciation & Amortization | 479K | 3.17M | 2.58M | 2.34M | 2.53M | 2.58M | 2.5M | 2.37M | 2.36M | 2.42M | 2.7M | 2.97M | 3.12M | 3.23M | 3.24M | 3.33M | 3.44M | 3.53M | 3.61M |